Literature DB >> 11313387

Quantitation of lysozyme peptides bound to class II MHC molecules indicates very large differences in levels of presentation.

C Velazquez1, R DiPaolo, E R Unanue.   

Abstract

Knowing the abundance of peptides presented by MHC molecules is a crucial aspect for understanding T cell activation and tolerance. In this report we determined the relative abundance of four distinct peptide families after the processing of the model Ag hen egg-white lysozyme. The development of a sensitive immunochemical approach reported here made it possible to directly quantitate the abundance of these four epitopes presented by APCs, both in vitro and in vivo. We observed a wide range of presentation among these four different epitopes presented on the surface of APCs, with 250-fold differences or more between the most abundant epitope (48-63) and the least abundant epitopes. Importantly, we observe similar ratios of presentation from APCs in vitro as well as from APCs from the spleens and thymi of hen egg-white lysozyme transgenic mice. We discuss the relationship between the amount of peptide presented and their binding to I-A(k) molecules, immunogenicity, and tolerogenicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313387     DOI: 10.4049/jimmunol.166.9.5488

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Antigen-specific dose-dependent system for the study of an inheritable and reversible phenotype in mouse CD4+ T cells.

Authors:  Eduardo J Firpo; Raymond K Kong; Qinghong Zhou; Alexander Y Rudensky; James M Roberts; B Robert Franza
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Distinct recognition by two subsets of T cells of an MHC class II-peptide complex.

Authors:  Zheng Pu; Javier A Carrero; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

Review 3.  Antigen presentation: lysoyme, autoimmune diabetes, and Listeria--what do they have in common?

Authors:  Emil Unanue; Craig Byersdorfer; Javier Carrero; Matteo Levisetti; Scott Lovitch; Zheng Pu; Anish Suri
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants.

Authors:  Chiao-Wen Yang; Beverly S I Strong; Mark J Miller; Emil R Unanue
Journal:  J Immunol       Date:  2010-08-02       Impact factor: 5.422

5.  Viral antigen density and confinement time regulate the reactivity pattern of CD4 T-cell responses to vaccinia virus infection.

Authors:  Vijay Vanguri; Christopher C Govern; Rebecca Smith; Eric S Huseby
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

6.  Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells.

Authors:  Leonia Bozzacco; Haiqiang Yu; Henry A Zebroski; Jörn Dengjel; Haiteng Deng; Svetlana Mojsov; Ralph M Steinman
Journal:  J Proteome Res       Date:  2011-10-14       Impact factor: 4.466

7.  Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells.

Authors:  Jeremy Herzog; Yoichi Maekawa; Thomas P Cirrito; Beverly S Illian; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-18       Impact factor: 11.205

8.  Mapping the stochastic sequence of individual ligand-receptor binding events to cellular activation: T cells act on the rare events.

Authors:  Jenny J Y Lin; Shalini T Low-Nam; Katherine N Alfieri; Darren B McAffee; Nicole C Fay; Jay T Groves
Journal:  Sci Signal       Date:  2019-01-15       Impact factor: 8.192

9.  Thymus-blood protein interactions are highly effective in negative selection and regulatory T cell induction.

Authors:  Danielle F Atibalentja; Craig A Byersdorfer; Emil R Unanue
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides.

Authors:  Inna G Ovsyannikova; Kenneth L Johnson; David C Muddiman; Robert A Vierkant; Gregory A Poland
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.